Nucor (NUE) Competitors

Nucor has a beta of 1.89, meaning that its share price is 89% more volatile than the broader market. Comparatively, ATI has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market.

In the previous week, Nucor had 35 more articles in the media than ATI. MarketBeat recorded 57 mentions for Nucor and 22 mentions for ATI. ATI's average media sentiment score of 1.07 beat Nucor's score of 0.99 indicating that ATI is being referred to more favorably in the news media.

ATI has a net margin of 9.26% compared to Nucor's net margin of 7.99%. ATI's return on equity of 26.44% beat Nucor's return on equity.

76.5% of Nucor shares are held by institutional investors. 0.6% of Nucor shares are held by insiders. Comparatively, 1.0% of ATI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Nucor has higher revenue and earnings than ATI. Nucor is trading at a lower price-to-earnings ratio than ATI, indicating that it is currently the more affordable of the two stocks.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. ATI pays an annual dividend of $0.32 per share and has a dividend yield of 0.2%. Nucor pays out 17.9% of its earnings in the form of a dividend. ATI pays out 10.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years. Nucor is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Nucor currently has a consensus target price of $273.31, indicating a potential upside of 8.16%. ATI has a consensus target price of $176.78, indicating a potential downside of 6.27%. Given Nucor's higher possible upside, equities analysts plainly believe Nucor is more favorable than ATI.

Cabot currently has a consensus price target of $85.80, suggesting a potential downside of 4.51%. Nucor has a consensus price target of $273.31, suggesting a potential upside of 8.16%. Given Nucor's stronger consensus rating and higher probable upside, analysts clearly believe Nucor is more favorable than Cabot.

93.2% of Cabot shares are held by institutional investors. Comparatively, 76.5% of Nucor shares are held by institutional investors. 3.1% of Cabot shares are held by company insiders. Comparatively, 0.6% of Nucor shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Nucor has higher revenue and earnings than Cabot. Cabot is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.1%. Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Cabot pays out 35.7% of its earnings in the form of a dividend. Nucor pays out 17.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has increased its dividend for 14 consecutive years and Nucor has increased its dividend for 52 consecutive years.

In the previous week, Nucor had 48 more articles in the media than Cabot. MarketBeat recorded 57 mentions for Nucor and 9 mentions for Cabot. Nucor's average media sentiment score of 0.99 beat Cabot's score of 0.76 indicating that Nucor is being referred to more favorably in the news media.

Cabot has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, Nucor has a beta of 1.89, meaning that its stock price is 89% more volatile than the broader market.

Nucor has a net margin of 7.99% compared to Cabot's net margin of 7.97%. Cabot's return on equity of 21.33% beat Nucor's return on equity.

In the previous week, Nucor had 49 more articles in the media than Chemours. MarketBeat recorded 57 mentions for Nucor and 8 mentions for Chemours. Nucor's average media sentiment score of 0.99 beat Chemours' score of 0.89 indicating that Nucor is being referred to more favorably in the media.

Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.1%. Nucor pays out 17.9% of its earnings in the form of a dividend. Chemours pays out -13.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

Nucor has a beta of 1.89, meaning that its stock price is 89% more volatile than the broader market. Comparatively, Chemours has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market.

Nucor has higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

Nucor has a net margin of 7.99% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Nucor's return on equity.

Nucor presently has a consensus price target of $273.31, suggesting a potential upside of 8.16%. Chemours has a consensus price target of $24.10, suggesting a potential upside of 43.80%. Given Chemours' higher probable upside, analysts plainly believe Chemours is more favorable than Nucor.

76.5% of Nucor shares are owned by institutional investors. Comparatively, 76.3% of Chemours shares are owned by institutional investors. 0.6% of Nucor shares are owned by company insiders. Comparatively, 0.9% of Chemours shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Nucor has a net margin of 7.99% compared to Celanese's net margin of -11.54%. Nucor's return on equity of 12.73% beat Celanese's return on equity.

Nucor has higher revenue and earnings than Celanese. Celanese is trading at a lower price-to-earnings ratio than Nucor, indicating that it is currently the more affordable of the two stocks.

98.9% of Celanese shares are owned by institutional investors. Comparatively, 76.5% of Nucor shares are owned by institutional investors. 0.3% of Celanese shares are owned by insiders. Comparatively, 0.6% of Nucor shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Nucor had 42 more articles in the media than Celanese. MarketBeat recorded 57 mentions for Nucor and 15 mentions for Celanese. Celanese's average media sentiment score of 1.10 beat Nucor's score of 0.99 indicating that Celanese is being referred to more favorably in the media.

Celanese has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market. Comparatively, Nucor has a beta of 1.89, meaning that its share price is 89% more volatile than the broader market.

Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.3%. Nucor pays an annual dividend of $2.24 per share and has a dividend yield of 0.9%. Celanese pays out -1.2% of its earnings in the form of a dividend. Nucor pays out 17.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nucor has increased its dividend for 52 consecutive years. Nucor is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Celanese currently has a consensus target price of $65.94, indicating a potential upside of 50.37%. Nucor has a consensus target price of $273.31, indicating a potential upside of 8.16%. Given Celanese's higher probable upside, analysts clearly believe Celanese is more favorable than Nucor.